Today Dr Pepper Snapple Group (DPS) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Dr Pepper Snapple Group ( DPS) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Dr Pepper Snapple Group as such a stock due to the following factors:

  • DPS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $121.8 million.
  • DPS has traded 3,924 shares today.
  • DPS is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in DPS with the Ticky from Trade-Ideas. See the FREE profile for DPS NOW at Trade-Ideas

More details on DPS:

Dr Pepper Snapple Group, Inc. operates as a brand owner, manufacturer, and distributor of non-alcoholic beverages in the United States, Canada, Mexico, and the Caribbean. The company operates in three segments: Beverage Concentrates, Packaged Beverages, and Latin America Beverages. The stock currently has a dividend yield of 3.1%. DPS has a PE ratio of 17.3. Currently there is 1 analyst that rates Dr Pepper Snapple Group a buy, 2 analysts rate it a sell, and 8 rate it a hold.

The average volume for Dr Pepper Snapple Group has been 2.2 million shares per day over the past 30 days. Dr Pepper Snapple Group has a market cap of $10.4 billion and is part of the consumer goods sector and food & beverage industry. The stock has a beta of 0.20 and a short float of 3.7% with 3.34 days to cover. Shares are up 7.9% year-to-date as of the close of trading on Monday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreetRatings.com Analysis:

TheStreet Quant Ratings rates Dr Pepper Snapple Group as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

Highlights from the ratings report include:
  • Net operating cash flow has increased to $250.00 million or 28.86% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -1.19%.
  • DR PEPPER SNAPPLE GROUP INC' earnings per share from the most recent quarter came in slightly below the year earlier quarter. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, DR PEPPER SNAPPLE GROUP INC increased its bottom line by earning $3.06 versus $2.96 in the prior year. This year, the market expects an improvement in earnings ($3.40 versus $3.06).
  • The gross profit margin for DR PEPPER SNAPPLE GROUP INC is rather high; currently it is at 61.79%. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of 10.66% trails the industry average.
  • Compared to where it was 12 months ago, the stock is up, but it has so far lagged the appreciation in the S&P 500. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns